Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

Further Topics

Heart Diseases

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

Metabolic Diseases

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95% of all cases. This number is projected to increase to 629 million people by 2045.

Chronic Kidney Disease

Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.

Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers.

Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

Mental Health

At Boehringer Ingelheim, we aspire to provide mental health treatment approaches that places an individual’s specific needs at the centre.

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.

Our Responsibility

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.

NP-GB-107620 June 2026

References